“DEPO MEDROKSI PROGESTERON ASETAT (DMPA) INCREASES BODY MASS INDEX OF ACCEPTORS BUT DECREASES THEIR LIBIDO”, Proceedings of the ICASH, no. 2, pp. 81–85, Sep. 2017, Accessed: Apr. 16, 2026. [Online]. Available: https://www.inschool.id/publications/index.php/icash/article/view/880